Breaking news

International SMA gene therapy trials to start in 2018

AveXis is expanding its spinal muscular atrophy clinical development programme for AVXS-101, and have announced plans for three new gene therapy trials.

Read more
Keep in touch
X
- Enter Your Location -
- or -